Top Markets
Coin of the day
NexgenRx Inc. NexgenRx Inc.

NexgenRx Inc.

NEGXF
Rank in Stocks #29069
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a... NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for prescription drug, dental, and various other extended healthcare claims for individuals covered by plans offered by its clients across Canada. Beyond core claims handling, NexgenRx offers Health Care Spending Accounts (HCSAs), providing individuals with dedicated funds for their health or dental expenses. Its service portfolio also encompasses individual and aggregate stop-loss insurance products, emergency medical and travel assistance insurance, and a suite of administrative support functions. These administrative services include the collection and disbursement of premiums for life and long-term disability (LTD) coverage, complemented by advanced reporting tools. To enhance convenience, the company facilitates online claims submission and direct deposit services, along with other specialized ancillary services.
Share Price
$0.325
Last synced: 2026-08-18
Market Cap
$23.11M
Change (1 day)
0.00%
Change (1 year)
62.50%
Country
CA
Trade NexgenRx Inc. (NEGXF)

Category

Revenue for NexgenRx Inc. (NEGXF)
Revenue in Aug 2026 TTM: 0
According to NexgenRx Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for NexgenRx Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$450.13B -
US
$415.09B -
US
$201.11B -
US
$282.38B -
US
$145.68B -
US